IDYA
Price
$30.36Alerts
Change
-$1.47 (-4.62%)
Updated
Nov 16 closing price
Capitalization
3.01B
98 days until earnings call
Intraday BUY SELL Signals
RCUS
Price
$16.86Alerts
Change
-$0.57 (-3.27%)
Updated
Nov 16 closing price
Capitalization
2.33B
105 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

IDYA vs RCUS

IDYA vs RCUS Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
IDYA vs. RCUS commentary
Nov 17, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IDYA is a Buy and RCUS is a Buy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for IDYA with price predictions
Nov 16, 2026

IDYA's RSI Oscillator ascends from oversold territory

The RSI Indicator for IDYA moved out of oversold territory on November 04, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 36 similar instances when the indicator left oversold territory. In 32 of the 36 cases the stock moved higher. This puts the odds of a move higher at 89%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 50 of 62 cases where IDYA's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 81%.

The Moving Average Convergence Divergence (MACD) for IDYA just turned positive on November 11, 2026. Looking at past instances where IDYA's MACD turned positive, the stock continued to rise in 42 of 48 cases over the following month. The odds of a continued upward trend are 88%.

Following a +4.50% 3-day Advance, the price is estimated to grow further. Considering data from situations where IDYA advanced for three days, in 217 of 288 cases, the price rose further within the following month. The odds of a continued upward trend are 75%.

IDYA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 29, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on IDYA as a result. In 80 of 107 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 75%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IDYA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 76%.

The Aroon Indicator for IDYA entered a downward trend on November 16, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 11 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.514) is normal, around the industry mean (3.586). P/E Ratio (-16.271) is within average values for comparable stocks, (-1.188). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (130.981) among similar stocks. P/S Ratio (14.409) is also within normal values, averaging (440.869).

The Tickeron PE Growth Rating for this company is 30 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 58 (best 1 - 100 worst), indicating steady price growth. IDYA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 82 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. IDYA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.

The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

A.I.Advisor
a Summary for RCUS with price predictions
Nov 16, 2026

RCUS in upward trend: price may jump up because it broke its lower Bollinger Band on November 16, 2026

RCUS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 29 of 33 cases where RCUS's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 88%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where RCUS's RSI Indicator exited the oversold zone, 29 of 34 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 85%.

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

The Moving Average Convergence Divergence (MACD) for RCUS just turned positive on November 04, 2026. Looking at past instances where RCUS's MACD turned positive, the stock continued to rise in 34 of 46 cases over the following month. The odds of a continued upward trend are 74%.

Following a +7.12% 3-day Advance, the price is estimated to grow further. Considering data from situations where RCUS advanced for three days, in 215 of 280 cases, the price rose further within the following month. The odds of a continued upward trend are 77%.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 12, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on RCUS as a result. In 69 of 94 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 73%.

The 50-day moving average for RCUS moved below the 200-day moving average on November 03, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RCUS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 80%.

The Aroon Indicator for RCUS entered a downward trend on November 02, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 14 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 61 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.016) is normal, around the industry mean (3.586). P/E Ratio (-4.640) is within average values for comparable stocks, (-1.188). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (130.981) among similar stocks. P/S Ratio (25.063) is also within normal values, averaging (440.869).

The Tickeron Price Growth Rating for this company is 80 (best 1 - 100 worst), indicating slightly worse than average price growth. RCUS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of 95 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RCUS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

FUNDAMENTALS RATINGS
IDYA vs RCUS: Fundamental Ratings
IDYA
RCUS
OUTLOOK RATING
1..100
1831
VALUATION
overvalued / fair valued / undervalued
1..100
11
Undervalued
61
Fair valued
PROFIT vs RISK RATING
1..100
82100
SMR RATING
1..100
9498
PRICE GROWTH RATING
1..100
5880
P/E GROWTH RATING
1..100
3014
SEASONALITY SCORE
1..100
5090

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IDYA's Valuation (11) in the null industry is somewhat better than the same rating for RCUS (61) in the Pharmaceuticals Major industry. This means that IDYA’s stock grew somewhat faster than RCUS’s over the last 12 months.

IDYA's Profit vs Risk Rating (82) in the null industry is in the same range as RCUS (100) in the Pharmaceuticals Major industry. This means that IDYA’s stock grew similarly to RCUS’s over the last 12 months.

IDYA's SMR Rating (94) in the null industry is in the same range as RCUS (98) in the Pharmaceuticals Major industry. This means that IDYA’s stock grew similarly to RCUS’s over the last 12 months.

IDYA's Price Growth Rating (58) in the null industry is in the same range as RCUS (80) in the Pharmaceuticals Major industry. This means that IDYA’s stock grew similarly to RCUS’s over the last 12 months.

RCUS's P/E Growth Rating (14) in the Pharmaceuticals Major industry is in the same range as IDYA (30) in the null industry. This means that RCUS’s stock grew similarly to IDYA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IDYARCUS
RSI
ODDS (%)
Bullish Trend 1 day ago
89%
Bullish Trend 1 day ago
85%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
83%
Momentum
ODDS (%)
Bearish Trend 1 day ago
75%
Bearish Trend 1 day ago
73%
MACD
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
74%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
78%
Bearish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
78%
Advances
ODDS (%)
Bullish Trend 8 days ago
75%
Bullish Trend 8 days ago
77%
Declines
ODDS (%)
Bearish Trend 14 days ago
76%
Bearish Trend 1 day ago
80%
BollingerBands
ODDS (%)
Bullish Trend 5 days ago
78%
Bullish Trend 1 day ago
88%
Aroon
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
84%
COMPARISON
Comparison
Nov 17, 2026
Stock price -- (IDYA: $30.36 vs. RCUS: $16.86)
Brand notoriety: IDYA and RCUS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IDYA: 55% vs. RCUS: 54%
Market capitalization -- IDYA: $3.01B vs. RCUS: $2.33B
IDYA [@Biotechnology] is valued at $3.01B. RCUS’s [@Biotechnology] market capitalization is $2.33B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $138.67B. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IDYA’s FA Score shows that 2 FA rating(s) are green while RCUS’s FA Score has 1 green FA rating(s).

  • IDYA’s FA Score: 2 green, 3 red.
  • RCUS’s FA Score: 1 green, 4 red.
According to our system of comparison, IDYA is a better buy in the long-term than RCUS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IDYA’s TA Score shows that 5 TA indicator(s) are bullish while RCUS’s TA Score has 5 bullish TA indicator(s).

  • IDYA’s TA Score: 5 bullish, 3 bearish.
  • RCUS’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, IDYA is a better buy in the short-term than RCUS.

Price Growth

IDYA (@Biotechnology) experienced а -5.21% price change this week, while RCUS (@Biotechnology) price change was -11.03% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -9.73%. For the same industry, the average monthly price growth was -7.91%, and the average quarterly price growth was -21.89%.

Reported Earning Dates

IDYA is expected to report earnings on Feb 23, 2027.

RCUS is expected to report earnings on Mar 02, 2027.

Industries' Descriptions

@Biotechnology (-9.73% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
Interact to see
Advertisement

RCUS and

Correlation & Price change

A.I.dvisor indicates that over the last year, RCUS has been loosely correlated with VIR. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if RCUS jumps, then VIR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RCUS
1D Price
Change %
RCUS100%
-3.27%
VIR - RCUS
50%
Loosely correlated
-3.82%
DYN - RCUS
47%
Loosely correlated
-2.68%
KURA - RCUS
46%
Loosely correlated
-8.75%
RCKT - RCUS
44%
Loosely correlated
-6.09%
IDYA - RCUS
43%
Loosely correlated
-4.62%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
FIGB41.270.06
+0.15%
Fidelity Investment Grade Bond ETF (FIGB)
RLTY14.60-0.06
-0.41%
Cohen & Steers Real Estate Opportunities and Income Fund
INKM33.72-0.15
-0.45%
State Street Income Allocation ETF (INKM)
MOTG40.30-0.40
-0.98%
VanEck Morningstar Global Wide Moat ETF (MOTG)
XLIX21.31-1.03
-4.60%
Corgi U.S. Industrials 2x Daily ETF (XLIX)